PIZZOLO, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 21.703
EU - Europa 15.779
AS - Asia 10.982
SA - Sud America 1.405
AF - Africa 101
OC - Oceania 39
Continente sconosciuto - Info sul continente non disponibili 19
Totale 50.028
Nazione #
US - Stati Uniti d'America 21.483
GB - Regno Unito 6.099
SG - Singapore 4.407
CN - Cina 4.212
IT - Italia 1.535
SE - Svezia 1.494
BR - Brasile 1.255
DE - Germania 1.251
FR - Francia 1.224
RU - Federazione Russa 1.154
IE - Irlanda 1.098
HK - Hong Kong 1.081
FI - Finlandia 1.071
UA - Ucraina 405
KR - Corea 339
VN - Vietnam 159
JP - Giappone 147
TR - Turchia 130
CA - Canada 121
BE - Belgio 115
IN - India 107
NL - Olanda 62
IR - Iran 61
BD - Bangladesh 55
ID - Indonesia 52
AR - Argentina 51
MX - Messico 50
PL - Polonia 41
ES - Italia 39
ZA - Sudafrica 37
IQ - Iraq 32
AU - Australia 29
PK - Pakistan 28
UZ - Uzbekistan 28
CZ - Repubblica Ceca 27
EC - Ecuador 23
CH - Svizzera 22
AT - Austria 21
RO - Romania 21
LT - Lituania 17
VE - Venezuela 15
AZ - Azerbaigian 14
CO - Colombia 14
MA - Marocco 14
BG - Bulgaria 13
EU - Europa 13
IL - Israele 13
PE - Perù 13
PY - Paraguay 12
AE - Emirati Arabi Uniti 11
NP - Nepal 11
EG - Egitto 10
KG - Kirghizistan 10
PA - Panama 10
CL - Cile 9
JO - Giordania 9
NZ - Nuova Zelanda 9
SA - Arabia Saudita 9
KZ - Kazakistan 8
BO - Bolivia 7
HU - Ungheria 7
KE - Kenya 7
LB - Libano 7
LV - Lettonia 7
TN - Tunisia 7
TT - Trinidad e Tobago 7
AL - Albania 6
CR - Costa Rica 6
DZ - Algeria 6
SN - Senegal 6
A2 - ???statistics.table.value.countryCode.A2??? 5
DO - Repubblica Dominicana 5
JM - Giamaica 5
NO - Norvegia 5
PT - Portogallo 5
UY - Uruguay 5
BH - Bahrain 4
DK - Danimarca 4
EE - Estonia 4
HN - Honduras 4
KW - Kuwait 4
LA - Repubblica Popolare Democratica del Laos 4
MY - Malesia 4
OM - Oman 4
PH - Filippine 4
SK - Slovacchia (Repubblica Slovacca) 4
TG - Togo 4
TW - Taiwan 4
AM - Armenia 3
BY - Bielorussia 3
LK - Sri Lanka 3
LU - Lussemburgo 3
MD - Moldavia 3
ME - Montenegro 3
PS - Palestinian Territory 3
RS - Serbia 3
TH - Thailandia 3
YE - Yemen 3
BB - Barbados 2
CM - Camerun 2
Totale 49.985
Città #
Southend 5.299
Jacksonville 3.685
Chandler 2.484
Dallas 2.356
Singapore 2.134
Woodbridge 2.116
Ann Arbor 1.394
Ashburn 1.360
Houston 1.172
Dublin 1.096
Hong Kong 1.073
Beijing 518
Wilmington 472
Lawrence 445
Princeton 445
Jinan 444
Nanjing 413
Shenyang 352
Los Angeles 317
New York 305
Buffalo 247
Hebei 229
The Dalles 218
Boardman 201
Verona 195
Sindelfingen 185
Tianjin 180
Munich 179
Helsinki 165
Columbus 156
Changsha 151
Zhengzhou 150
Nanchang 142
Milan 133
Haikou 131
Ningbo 123
Hangzhou 122
Taizhou 113
Brussels 110
Jiaxing 107
São Paulo 103
Guangzhou 91
Santa Clara 90
Philadelphia 87
Seattle 86
Taiyuan 86
Washington 80
Council Bluffs 78
Falls Church 75
Turku 75
Seoul 74
Redondo Beach 73
Norwalk 71
Tokyo 67
Lancaster 66
Rome 59
San Francisco 58
Dearborn 57
Fuzhou 57
Auburn Hills 56
Düsseldorf 51
Redmond 49
Toronto 48
Fairfield 47
Lanzhou 46
Frankfurt am Main 39
Brooklyn 38
Ho Chi Minh City 37
Jakarta 35
Rio de Janeiro 35
Chicago 34
Moscow 34
Dong Ket 30
Cambridge 29
London 29
Stockholm 29
Boston 28
Leawood 28
Montreal 28
Redwood City 27
Warsaw 27
Hanoi 26
Tashkent 26
Bologna 25
Kochi 24
Nuremberg 23
Kent 22
Zanjan 22
Manchester 21
Belo Horizonte 20
Brasília 20
Curitiba 19
Dhaka 19
Tappahannock 19
Paris 18
Amsterdam 17
Madrid 17
San Mateo 17
Chennai 16
Padova 16
Totale 33.741
Nome #
La citometria a flusso in Ematologia: aspetti tecnici e metodologici 441
Preferential release of high amounts of interleukin-8 by myeloid blasts showing monocytic differentiation 386
Immunocitologia e immunoistologia delle cellule midollari normali e neoplastiche 382
Valutazione immunofenotipica della malattia minima residua (MRD) nella leucemia acuta linfoblastica dell'adulto 299
Leucemia linfatica cronica/linfoma linfocitico (LLC): l'espressione di ZAP-70, analizzata alla diagnosi su biopsia ossea, è un importante fattore prognostico 283
Interferon-alpha-engineered Multipotent Mesenchymal Stromal Cells for the treatment of myeloma 239
A simplified immunological approach to the diagnosis of chronic lymphocytic leukaemia and other lymphoproliferative disorders 226
IFNalpha-producing bone marrow mesenchymal stem cells (BM-MSCs) contrast tumor growth in a mouse myeloma model. 210
Alpha (p55) and beta (p75) chains of the interleukin-2 receptor are expressed by AML blasts 210
a (p55) and b (p75) chains of interleukin-2 receptor are expressed by AML blasts 204
Acute lymphoblastic leukemia (ALL) in elderly patients receiving intensive treatment. Experience in 26 consecutive patients 197
A rapid immunostaining method for frozen sections 194
Endothelin B Receptor (Etbr) expression by human malignant plasma cells: preliminary evidence for a role of the endothelin axis in multiple myeloma. 189
DEATH RECEPTOR 3 EXPRESSION AND SERUM LEVEL OF SOLUBLE TL1A CORRELATE WITH INDOLENT, EARLY STAGE B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA 188
Acute lymphoblastic leukaemia after radiotherapy and adjuvant chemotherapy (CMF) for breast cancer. 187
Association between B-cell receptor responsiveness and disease progression in B-cell chronic lymphocytic leukemia: results from single cell network profiling studies 187
[Lung diseases during the course of systemic diseases: current clinico-radiological problems (proceedings)] 186
A study of the crosstalk between CD30 and CXCR4 185
Increased levels of soluble interleukin-2 receptor in the serum of patients with human immunodeficiency virus infection 184
HB-EGF/HER -1 SIGNALLING IN BONE MARROW MESENCHYMAL STEM CELLS: INDUCING CELL EXPANSION AND PREVENTING REVERSIBLY MULTI-LINEAGE DIFFERENTIATION 184
Acute leukemia and pregnancy. Case report 182
B-cell chronic lymphocytic leukemia cells espress functional death receptor 3 following stimulation of the B cell receptor 182
Abnormal expansions of polyclonal large to small size granular lymphocytes: reactive or neoplastic process? 176
Analysis of B-cell receptor signal transduction in B-cell chronic lymphocytic leukemia by phosphospecific flow-cytometry 176
NON-CANONICAL NOTCH SIGNALING IN T-ALL: A PHOSPHO-FLOW CYTOMETRY STUDY 175
Abnormal expression of the p53-binding protein MDM2 in Hodgkin's disease 175
Serum levels of soluble interleukin-2 receptor in hairy cell leukaemia: a reliable marker of neoplastic bulk 174
The diagnostic value of serum copper levels and other hematochemical parameters in malignancies 171
Caratterizzazione immunofenotipica: principi ed applicazioni in Ematologia 169
Prognostic value of serum markers of established impact on prognosis in relation with ZAP-70 expression in B-CLL patients 167
A novel large-sized BCR-ABL transcript in a case of chronic myeloid leukaemia characterised by a favourable clinical course. 167
Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia 167
CAL2 Monoclonal Antibody Is a Rapid and Sensitive Assay for the Detection of Calreticulin Mutations in Essential Thrombocythemia and May Provide Prognostic Informations 167
Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events 165
A proliferation-inducing ligand (APRIL) serum levels predict time to first treatment in patients affected by B-cell chronic lymphocytic leukemia 165
Novel stem/progenitor cells with neuronal differentiation potential reside in the leptomeningeal niche 164
Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways 162
Cellular senescence markers p16INK4 and p21CIP1/WAF are predictors of Hodgkin's lymphoma outcome 162
EXPRESSION AND FUNCTIONAL ACTIVITY OF DEATH RECEPTOR 3 IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA 161
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 159
SINGLE-CELL PROFILES OF B-CELL RECEPTOR PHOSPHO-PROTEIN NETWORKS ASSOCIATED WITH PROGNOSIS AND PROGRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA 159
Blastic OKT6-positive proliferation preceding malignant histiocytosis 158
Role of stromal cell-mediated Notch signaling in CLL resistance to chemotherapy 158
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 157
Fluoride resistant alpha-naphthyl acetate esterase and combined enzyme histochemistry in the study of normal and pathologic lymphoid tissues 155
CXCL8 and interleukin-6 in B-cell chronic lymphocytic leukemia are up-reuglated through the activity of CXCL12 155
CXCL12-MEDIATED NF-KAPPAB AND C-JUN ACTIVATION REGULATES INTERLEUKIN 8 PRODUCTION IN HUMAN T-LYMPHOBLASTIC LEUKEMIA 155
Expression of extracellular matrix molecules, proliferation markers and cyclin-dependent kinase inhibitors in inflamed tissues 154
An unusual case of acute leukaemia 154
[Haemolytic anaemia associated with acquired deficiency of erythrocyte glutathione peroxidase: use of sodium selenite to correct the enzyme defect (author's transl)] 154
Induction of neural-like differentiation in human mesenchymal stem cells derived from bone marrow, fat, spleen and thymus 154
Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial 154
Immunohistochemical differentiation of follicular lymphoma from florid reactive follicular hyperplasia with monoclonal antibodies reactive on paraffin sections 152
Homing and Efficacy Assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmocytoma model 152
Efficacy assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmacytoma model 152
A preliminary experience with the HyperCHiDAM Verona intensive chemotherapy regimen in heavily pretreated refractory Hodgkin's lymphoma 152
BCR-signaling profiles associated with prognosis and progression in B-CLL 152
Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia 152
Constitutive expression of tenascin in T-dependent zones of human lymphoid tissues 150
CXCL8/interleukin 8 in B-cell chronic lymphocytic leukemia is up-regulated through the activity of the CXCL12/CXCR4 axis 150
Erectile Dysfunction after Allogeneic Hematopoietic Stem Cell Transplant: Results from a Single Center Experience 150
B cells in chronic lymphocytic leukaemia. Comparative analysis of blood and bone marrow 149
Prognostic factors in acute non-lymphocytic leukemia with respect to treatment response 149
Activated T cells with immunoregulatory functions at different sites of involvement in sarcoidosis. Phenotypic and functional evaluations 148
Hyaline-vascular type of Castleman's disease (angiofollicular lymph node hyperplasia) with monotypic plasma cells. An immunohistochemical study with monoclonal antibodies 148
BCR-signaling profiles associated with prognosis and progression in B-CLL 148
ANTI-MÜLLERIAN HORMONE AND ANTRAL FOLLICLE COUNT REVEAL A LATE IMPAIR- MENT OF OVARIAN RESERVE IN PATIENTS UNDERGONE LOW GONADOTOXIC REGIMENS FOR HAEMATOLOGICAL MALIGNANCIES 148
Autoimmune complications are frequent in splenic and nodal marginal zone lymphomas 147
Espressione del CD30 ligando sulle cellule di differenti neoplasie ematologiche leucemiche 146
Natural killer cell function and lymphoid subpopulations in acute non-lymphoblastic leukaemia in complete remission 146
Biological prognostic factors in indolent lymphoma 145
HUMAN T-LYMPHOBLASTIC LEUKAEMIA CELLS PRODUCE IL-8 IN RESPONSE TOCXCL12 SECRETED BY NORMAL BONE MARROW STROMA 145
Neoplastic epithelial cells in a subset of human thymomas express the B cell-associated CD20 antigen 143
High serum levels of soluble interleukin 2 receptor in patients with B chronic lymphocytic leukemia 143
PROGNOSTIC VALUE OF SERUM THYMIDINE KINASE LEVEL AND ZAP-70 EXPRESSION DETECTED BY IMMUNOHISTOCHEMISTRY ON BONE MARROW BIOPSIES IN B-CLL: COMPARATIVE ANALYSIS 143
REDOX SIGNALING HYPERSENSITIVITY DISTINGUISHES CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH FAVORABLE PROGNOSIS 143
Ceftazidime and amikacin as empiric antibiotic therapy of febrile granulocytopenic patients with hematological malignancies. Report of 171 consecutive episodes 142
I marcatori delle cellule linfoidi 142
METHODOLOGICAL APPROACH TO MINIMAL RESIDUAL DISEASE DETECTION BY FLOW CYTOMETRY IN ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA 142
Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicin 141
Allergen specific immunotherapy is safe and effective in patients with systemic mastocytosis and hymenopteria allergy 141
[Immunology of the lymphatic follicle] 140
Espressione e ruolo funzionale di CD30/CD30L e Fas/FasL in cellule endoteliali umane 140
Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant alpha-interferon therapy on clinical parameters and natural killer in vitro activity 140
Detection of calbindin-D immunoreactivity in human follicular dendritic cells 140
α-bisabolol is an effective proapoptotic agent against BCR-ABL+ cells in synergism with Imatinib and Nilotinib 140
Predictors of stable deep molecular response in chronic phase chronic myeloid leukemia patients treated with dasatinib or nilotinib after imatinib failure 140
G-CSF-stimulated neutrophils are a prominent source of functional BLyS 140
IL-8 mRNA expression and IL-8 production by acute myeloid leukemia cells 139
Immunologic abnormalities in angioimmunoblastic lymphadenopathy 139
IN VITRO STUDY OF THE MECHANISMS INVOLVED IN THE BONE MARROW MESENCHY- MAL STROMAL CELL MODULATORY EFFECT ON B CELL FUNCTIONS 139
BONE MARROW-DERIVED STROMAL CELLS INHIBIT SPONTANEOUS APOPTOSIS IN NORMAL AND NEOPLASTIC THYMOCYTES 139
Oral itraconazole plus nasal amphotericin B for prophylaxis of invasive aspergillosis in patients with hematological malignancies 139
Expression and role of CD30/CD30L and Fas/FasL in human endothelial cells 138
Soluble interleukin-2 receptor in the serum of patients with Hodgkin's Disease: A new biological marker of disease activity 138
Improved prognosis of Pseudomonas aeruginosa bacteremia in 127 granulocytopenic patients with hematological malignancies 136
Highly concentrated urine-purified Tac peptide fails to inhibit IL-2-dependent cell proliferation in vitro 136
The Sesquiterpene Oil {alpha}-Bisabolol Induces Apoptosis of B-Chronic Lymphocytic Leukemia Primary Cells 136
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 136
Common acute lymphoblastic leukaemia-lymphoma expressing cytokeratin: a case report 135
Totale 16.905
Categoria #
all - tutte 163.849
article - articoli 118.058
book - libri 0
conference - conferenze 43.693
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.098
Totale 327.698


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.442 0 0 0 500 537 613 58 419 372 40 700 203
2021/20223.812 331 1.091 44 264 212 118 76 203 135 142 389 807
2022/20237.250 582 583 658 1.295 744 1.768 59 473 771 42 181 94
2023/20243.451 174 297 300 391 356 501 188 431 18 124 409 262
2024/20258.611 600 595 220 1.458 472 279 318 383 1.323 475 706 1.782
2025/20265.834 1.866 1.831 1.905 232 0 0 0 0 0 0 0 0
Totale 50.339